PercuSurge GuardWire Associated With Fewer Adverse Cardiac Events

A comparatively low rate of major adverse cardiac events (MACE) in patients treated with Medtronic/PercuSurge's GuardWire distal protection device during saphenous vein graft repair procedures contributed to a favorable FDA panel review, despite concerns about the device's malfunction rate.

More from Archive

More from Medtech Insight